This is a short idea I came across by accident. I was looking at charts and came across this nice high priced but weak and toppy looking chart on both a Monthly and Weekly basis. This company “provides sequencing and array-based solutions for genetic and genomic analysis.” I can’t say much from a fundamental perspective as I am not familiar with the booming genome sequencing business, but all I can say is that trajectory has been down since 2021 and it can’t seem to get off the ground down here in the $200 area.
This has a rather high PE Ratio above 40 (not extreme, but also a bit bloated for the current market environment). Those weak stocks are my favorite to short because resistance just tends to hold so much more easily than trying to time the general market or market leaders.
(more…)



